Routing of drug supply for military personnel in military medical organizations
- Authors: Miroshnichenko Y.V.1, Ivanov V.V.1, Rodionov E.O.1, Kostenko N.L.1, Shcherba M.P.1
-
Affiliations:
- The S.M.Kirov Military Medical Academy
- Issue: Vol 343, No 2 (2022)
- Pages: 61-64
- Section: Brief articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/629764
- DOI: https://doi.org/10.52424/00269050_2022_343_2_61
- ID: 629764
Cite item
Open Access
Access granted
Subscription Access
Abstract
The article is devoted to the problem of ensuring the continuity and consistency of pharmacotherapy in the treatment or medical rehabilitation of servicemen in the treatment-and-prophylactic and sanatorium-resort organizations of the RF Ministry of Defense. It is proposed to include information on the prescription and use of drugs in the medical record of a serviceman. The presence of these data will provide the doctor with objective information about the previous use of drugs in sequential treatment. The routing and continuity of pharmacotherapy will allow preventing an interruption in the intake of drugs by patients when they go to the place of treatment (medical rehabilitation), to exclude cases of excess delivery (consumption) of drugs. In addition, this will make it possible to record information about the emergence of drug resistance in a serviceman, adverse reactions.
About the authors
Yu. V. Miroshnichenko
The S.M.Kirov Military Medical Academy
Author for correspondence.
Email: miryv61@gmail.com
Russian Federation, St. Petersburg
V. V. Ivanov
The S.M.Kirov Military Medical Academy
Email: miryv61@gmail.com
Russian Federation, St. Petersburg
E. O. Rodionov
The S.M.Kirov Military Medical Academy
Email: miryv61@gmail.com
Russian Federation, St. Petersburg
N. L. Kostenko
The S.M.Kirov Military Medical Academy
Email: miryv61@gmail.com
Russian Federation, St. Petersburg
M. P. Shcherba
The S.M.Kirov Military Medical Academy
Email: miryv61@gmail.com
Russian Federation, St. Petersburg
References
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).